P450c17 Mutations R347H and R358Q Selectively Disrupt 17,20-Lyase Activity by Disrupting Interactions with P450 Oxidoreductase and Cytochrome b5
Open accessThe DOI matches its Crossref record; 33 of the 34 references it cites were found in a registry or an index.
Abstract
Cytochrome P450c17 catalyzes steroid 17alpha-hydroxylase and 17,20-lyase activities and hence is a key enzyme in the production of human glucocorticoids and sex steroids. These two activities are catalyzed in a single substrate-binding site but are regulated independently in human physiology. We have recently shown that cytochrome b5 facilitates 17,20-lyase activity by allosterically promoting the interaction of P450c17 with P450 oxidoreductase (OR) and that the human P450c17 mutations, R347H and R358Q, selectively destroy 17,20-lyase activity while sparing 17alpha-hydroxylase activity. We transfected COS-1 cells with vectors for these P450c17 mutants and found that an excess of OR and b5 restored a small amount of 17,20-lyase activity, suggesting the mutations interfere with electron donation. To determine whether these mutations selectively interfere with the interaction of P450c17 and its electron-donating system, we expressed each P450cl7 mutant in yeast with or without OR, b5, or both, and measured enzyme kinetics in yeast microsomes using pregnenolone and 17alpha-hydroxypregnenolone as substrates. The apparent Michaelis-Menten (Km) values for the R347H mutant with and without coexpressed OR were 0.2 and 0.6 microM, respectively, and for the R358Q mutant with and without OR they were 0.3 and 0.4 microM, respectively; these values did not differ significantly from the wild-type values of 0.4 and 0.8 microM with and without OR, respectively. Furthermore, coincubation with 17alpha-hydroxypregnenolone showed a competitive mechanism for interference of catalysis. The similar kinetics and the competitive inhibition prove that the mutations did not affect the active site. Coexpression of the mutants with OR yielded insignificant 17,20-lyase activity, but addition of a 30:1 molar excess cytochrome b5 to these microsomes restored partial 17,20-lyase activity, with the R358Q mutant achieving twice the activity of the R347H mutant. These data indicate that both mutations selectively interfere with 17,20-lyase activity by altering the interaction of P450c17 with OR, thus proving that the lyase activity was disrupted by interfering with electron transfer. Furthermore, the data offer the first evidence that R347 is a crucial component of the site at which b5 interacts with the P450c17 x OR complex to promote electron transfer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“and enzymatic competition experiments showed that the substrate binding site remained normal (280).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [280]
In the citing paper
“When an excess of POR and cytochrome b 5 was provided, some 17,20-lyase activity was restored, demonstrating that the loss in lyase activity was caused by impaired electron transfer (280).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [280]
In the citing paper
“When assayed in vitro, both mutants retained nearly normal 17␣-hydroxylase activity but had no detectable 17,20-lyase activity (279, 280),”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [280]
In the citing paper
“The model identifies Arg 347 and Arg 358 and several other arginine and lysine residues in the redox partner binding site; mutations of these residues all cause varying degrees of selective loss of 17,20lyase activity (240, 279, 280, 284).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [280]
In the citing paper
“Because the 17,20-lyase activity of P450c17 is especially sensitive to perturbations in electron transport (49, 279, 280), defects in fetal testicular steroidogenesis leading to incompletely developed external genitalia in 46,XY males is the predicted outcome.”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [280]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
The Carbon Monoxide-binding Pigment of Liver Microsomes
Omura, T., & Sato, R. (1964) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)82244-3 · Cited by 11,781
Improved method for high efficiency transformation of intact yeast cells
Gietz, D., Jean, A. S., Woods, R. A., & Schiestl, R. H. (1992) · Nucleic Acids Research · doi:10.1093/nar/20.6.1425 · Cited by 3,261
ORENTREICH, N., BRIND, J. L., RIZER, R. L., & VOGELMAN, J. H. (1984) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-59-3-551 · Cited by 1,349
[6] Yeast expression of animal and plant P450s in optimized redox environments
Pompon, D., Louerat, B., Bronine, A., & Urban, P. (1996) · Methods in Enzymology · doi:10.1016/s0076-6879(96)72008-6 · Cited by 653
Cytochrome b 5 Augments the 17,20-Lyase Activity of Human P450c17 without Direct Electron Transfer
Auchus, R. J., Lee, T. C., & Miller, W. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.6.3158 · Cited by 541
Self-citationZhang, L. H., Rodriguez, H., Ohno, S., & Miller, W. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.23.10619 · Cited by 455
Self-citationChung, B. C., Picado-Leonard, J., Haniu, M., Bienkowski, M., Hall, P. F., Shively, J. E., & Miller, W. L. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.2.407 · Cited by 444
Self-citationPICADO-LEONARD, J., & MILLER, W. L. (1987) · DNA · doi:10.1089/dna.1987.6.439 · Cited by 415
Self-citation17α-Hydroxylase/17,20 lyase deficiency: from clinical investigation to molecular definition
YANASE, T., SIMPSON, E. R., & WATERMAN, M. R. (1991) · Endocrine Reviews · doi:10.1210/edrv-12-1-91 · Cited by 390
The genetic and functional basis of isolated 17,20 lyase deficiency
Geller, D. H., Auchus, R. J., Mendonça, B. B., & Miller, W. L. (1997) · Nature Genetics · doi:10.1038/ng1097-201 · Cited by 318
Self-citation
Cited by
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
Miller, W. L., & Auchus, R. J. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0013 · Cited by 2,458
Self-citationCongenital adrenal hyperplasia due to 21-hydroxylase deficiency*
White, P. C., & Speiser, P. W. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.3.0398 · Cited by 1,432
“In similar studies of CYP17, mutagenesis of arginine residues in this region disrupts interactions with cytochrome P450 reductase and cytochrome b5 (364).”
BackgroundMutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome
Flück, C. E., Tajima, T., Pandey, A. V., Arlt, W., Okuhara, K., Verge, C. F., Jabs, E. W., Mendonça, B. B., Fujieda, K., & Miller, W. L. (2004) · Nature Genetics · doi:10.1038/ng1300 · Cited by 509
Self-citationHuang, N., Pandey, A. V., Agrawal, V., Reardon, W., Lapunzina, P. D., Mowat, D., Jabs, E. W., Vliet, G. V., Sack, J., Flück, C. E., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/429417 · Cited by 336
“In this system, a yeast strain lacking the gene for yeast POR was transiently transfected with vectors expressing human P450c17 and POR (Auchus et al. 1998).”
BackgroundMethodInfluentialSelf-citationMinireview: Regulation of Steroidogenesis by Electron Transfer
Miller, W. L. (2005) · Endocrinology · doi:10.1210/en.2005-0096 · Cited by 324
Self-citationGenetics of congenital adrenal hyperplasia
Krone, N., & Arlt, W. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.10.014 · Cited by 312
THE GENETICS, PATHOPHYSIOLOGX, AND MANAGEMENT OF HUMAN DEFICIENCIES OF P450c17
Auchus, R. J. (2001) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(08)70021-5 · Cited by 266
Self-citationWood, J. R., Nelson, V. L., Ho, C., Jansen, E., Wang, C. Y., Urbanek, M., McAllister, J. M., Mosselman, S., & Strauss, J. F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300688200 · Cited by 260
Steroid 17-hydroxylase and 17,20-lyase deficiencies, genetic and pharmacologic
Auchus, R. J. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.02.002 · Cited by 229
Self-citationCosta-Santos, M., Kater, C. E., & Auchus, R. J. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031021 · Cited by 224
“The serpiginous chain of residues that follows and leads to the heme-liganding cysteine (C442) tends to unwind the K helix, but hydrogen bonding between the adjacent E and R residues in this motif stabilizes this structure and helps to form the redox partner binding site (47, 51) (Fig.”
BackgroundSelf-citation46,XY disorders of sex development (DSD)
Mendonca, B. B., Domenice, S., Arnhold, I. J. P., & Costa, E. M. F. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03392.x · Cited by 204
The roles of cytochrome b5 in cytochrome P450 reactions
Porter, T. D. (2002) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.10052 · Cited by 193
“Stimulation by b5 is near-maximal at a 1:1 ratio of b5 to P450; further studies indicated that mutations on the likely redox partner binding surface of P450 greatly reduce the ability of cytochrome b5 to effect this stimulation [45].”
BackgroundAuchus, R. J., & Miller, W. L. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.7.0326 · Cited by 185
“Thus, the R347H and R358Q mutants have nearly the same Michaelis-Menten constant (Km) as the wild-type P450c17, but substantially slower Vmax for the 17ahydroxylase reaction (13).”
BackgroundMethodInfluentialSelf-citationAndrogen biosynthesis from cholesterol to DHEA
Miller, W. L. (2002) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(02)00363-5 · Cited by 179
Self-citationRegulation of 17,20 lyase activity by cytochrome b5 and by serine phosphorylation of P450c17
Pandey, A. V., & Miller, W. L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414673200 · Cited by 165
Self-citationArlt, W., Auchus, R. J., & Miller, W. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100040200 · Cited by 157
Self-citationThe syndrome of 17,20 lyase deficiency
Miller, W. L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2161 · Cited by 143
Self-citationProtein phosphatase 2A and phosphoprotein SET regulate androgen production by P450c17
Pandey, A. V., Mellon, S. H., & Miller, W. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209527200 · Cited by 137
Self-citationGilep, A. A., Sushko, T. A., & Usanov, S. A. (2010) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2010.06.021 · Cited by 145
Congenital adrenal hyperplasia and P450 oxidoreductase deficiency
Krone, N., Dhir, V., Ivison, H. E., & Arlt, W. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02740.x · Cited by 131
Sherbet, D. P., Tiosano, D., Kwist, K. M., Hochberg, Z., & Auchus, R. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307586200 · Cited by 131
Self-citationAndrogen synthesis in adrenarche
Miller, W. L. (2009) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-008-9102-4 · Cited by 127
“POR and P450c17, favoring the 17,20 lyase reaction [66, 81].”
BackgroundSelf-citationvan den Akker, E. L. T., Koper, J. W., Boehmer, A. L. M., Themmen, A. P. N., Verhoef-Post, M., Timmerman, M. A., Otten, B. J., Drop, S. L. S., & De Jong, F. H. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2001-011880 · Cited by 125
“Coexpression of the R347 and R358 mutants with P450 oxidoreductase did not result in a significant increase in 17,20-lyase activity, but addition of excess cytochrome b5 partially restored 17,20-lyase activity (20).”
BackgroundThe diverse chemistry of cytochrome P450 17A1 (P450c17, CYP17A1)
Yoshimoto, F. K., & Auchus, R. J. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.11.026 · Cited by 124
“Thin-layer chromatography (TLC) analysis is another option: radiolabeled steroids should be used ([14C]- or [3H]- labeled) to detect steroids by phosphorimaging [16] or by scraping the sections containing the steroids from the TLC plates for quantifyication by liquid scintillation counting.”
BackgroundMethodSelf-citationGenetic and clinical features of P450 oxidoreductase deficiency
Scott, R. R., & Miller, W. L. (2008) · Hormone Research in Paediatrics · doi:10.1159/000114857 · Cited by 115
Self-citationAdrenal Androgens and Androgen Precursors-Definition, Synthesis, Regulation and Physiologic Actions
Turcu, A., Smith, J. M., Auchus, R., & Rainey, W. E. (2014) · Comprehensive physiology · doi:10.1002/cphy.c140006 · Cited by 113
“While further study of steroidogenic enzymes is needed in 21OHD adrenals, the altered zonation may result in a replacement of the typical zona reticularis (which lacks HSD3B2, and thus favors DHEA synthesis) with areas that coexpress HSD3B2 along with CYB5A.”
InfluentialSelf-citationIsolated 17,20-lyase deficiency due to the cytochrome b5 mutation W27X
Kok, R. C., Timmerman, M. A., Wolffenbuttel, K. P., Drop, S. L. S., & de Jong, F. H. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1745 · Cited by 111
“influencing 17-hydroxylase activity (3, 4).”
BackgroundIdkowiak, J., Randell, T., Dhir, V., Patel, P., Shackleton, C. H. L., Taylor, N. F., Krone, N., & Arlt, W. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2413 · Cited by 104
Cytochrome b5 modulation of 17α hydroxylase and 17–20 lyase (CYP17) activities in steroidogenesis
Akhtar, M. K., Kelly, S. L., & Kaderbhai, M. A. (2005) · Journal of Endocrinology · doi:10.1677/joe.1.06375 · Cited by 120
“Furthermore, since the substrate affinities at the active sites of the CYP17 mutants Arg347 His and Arg358 Gln were found to be unaffected raised crucial questions as to how the mutations were able to selectively impair lyase activity of CYP17 (Geller et al. 1999).”
BackgroundHuman ovarian theca cells in culture
Wickenheisser, J. K., Nelson-DeGrave, V. L., & McAllister, J. M. (2006) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2006.01.003 · Cited by 112
Arlt, W., Martens, J. W. M., Song, M., Wang, J. T., Auchus, R. J., & Miller, W. L. (2002) · Endocrinology · doi:10.1210/en.2002-220456 · Cited by 101
“As 17,20 lyase activity is significantly enhanced by allosteric interaction of the P450c17/OR complex with b5 (14, 28), 17,20 lyase activity was measured in the presence of exogenously added b5.”
BackgroundSelf-citationSubstrate-modulated Cytochrome P450 17A1 and Cytochrome b5 Interactions Revealed by NMR
Estrada, D. F., Laurence, J. S., & Scott, E. E. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.468926 · Cited by 100
“These findings are in keeping with previous functional and genetic analysis of mutations at these same sites in the full-length proteins (11, 20, 23), thus indicating that the soluble domains interact in a manner consistent with the full-length variants.”
BackgroundResultBiason-Lauber, A., Zachmann, M., & Schoenle, E. J. (2000) · Endocrinology · doi:10.1210/endo.141.4.7402 · Cited by 98
Colocalization of P450c17 and Cytochrome b5 in Androgen-Synthesizing Tissues of the Human1
Dharia, S., Slane, A., Jian, M., Conner, M., Conley, A. J., & Parker, C. R. (2004) · Biology of Reproduction · doi:10.1095/biolreprod.103.026732 · Cited by 96
“Further evidence for selective regulation of 17,20-lyase activity is provided by studies on mutations of the P450c17 gene [17, 18], located on chromosome 10q24.”
Hershkovitz, E., Parvari, R., Wudy, S. A., Hartmann, M. F., Gomes, L. G., Loewental, N., & Miller, W. L. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0051 · Cited by 95
Self-citationThe metabolism, analysis, and targeting of steroid hormones in breast and prostate cancer
Capper, C. P., Rae, J. M., & Auchus, R. J. (2016) · Hormones and Cancer · doi:10.1007/s12672-016-0259-0 · Cited by 89
“CYP17A1’s 17,20-lyase activity is enhanced by the coexpression of cytochrome b5 (CYB5A), which allosterically stimulates this reaction [13, 14].”
BackgroundSelf-citationConsequences of POR mutations and polymorphisms
Miller, W. L., Agrawal, V., Sandee, D., Tee, M. K., Huang, N., Choi, J. H., Morrissey, K., & Giacomini, K. M. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.10.022 · Cited by 88
“The 17,20 lyase activity of P450c17 is especially sensitive to perturbations in electron transport (Geller et al., 1997; Geller et al., 1999; Miller, 2005), thus affected males are hypo-androgenic.”
BackgroundSelf-citationRobins, T., Carlsson, J., Sunnerhagen, M., Wedell, A., & Persson, B. (2006) · Molecular Endocrinology · doi:10.1210/me.2006-0172 · Cited by 87
5α-Reduced C21 steroids are substrates for human cytochrome P450c17
Gupta, M. K., Guryev, O. L., & Auchus, R. J. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2003.07.003 · Cited by 84
Self-citationMonogenic disorders of adrenal steroidogenesis
Baranowski, E. S., Arlt, W., & Idkowiak, J. (2018) · Hormone Research in Paediatrics · doi:10.1159/000488034 · Cited by 79
Human Cytochrome P450 Cancer-Related Metabolic Activities and Gene Polymorphisms: A Review
Mokhosoev, I. M., Astakhov, D. V., Terentiev, A. A., & Moldogazieva, N. T. (2024) · Cells · doi:10.3390/cells13231958 · Cited by 84
Wood, J. R., Nelson-Degrave, V. L., Jansen, E., McAllister, J. M., Mosselman, S., & Strauss, J. F. (2005) · Physiological Genomics · doi:10.1152/physiolgenomics.00193.2004 · Cited by 78
“One explanation for these data is that the theca cells were not stimulated with forskolin, resulting in levels of CYP17 and CYP11A mRNA that are below the sensitivity of the Affymetrix oligonucleotide probe set used in the analysis.”
BackgroundInfluentialMiller, W. L. (2004) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2004.07.005 · Cited by 82
Self-citation46,XY DSD due to impaired androgen production
Mendonca, B. B., Costa, E. M. F., Belgorosky, A., Rivarola, M. A., & Domenice, S. (2010) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2009.11.003 · Cited by 78
P450c17 deficiency: clinical and molecular characterization of six patients
Rosa, S., Duff, C., Meyer, M., Lang-Muritano, M., Balercia, G., Boscaro, M., Kemal Topaloglu, A., Mioni, R., Fallo, F., Zuliani, L., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1486 · Cited by 71
“hanced by the interaction with redox partners (3, 4).”
BackgroundLin, C. J., Martens, J. W. M., & Miller, W. L. (2001) · Molecular Endocrinology · doi:10.1210/mend.15.8.0679 · Cited by 71
Self-citationLee, T. C., Miller, W. L., & Auchus, R. J. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.6.5646 · Cited by 71
“We recently described a yeast system in which the enzymology of human P450c17 can be studied with precision (11) and used this system to delineate the enzymology of P450c17 mutants that have an isolated loss of 17,20-lyase activity (34).”
MethodSelf-citationTiosano, D., Knopf, C., Koren, I., Levanon, N., Hartmann, M. F., Hochberg, Z., & Wudy, S. A. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0712 · Cited by 71
Hlavica, P., Schulze, J., & Lewis, D. F. V. (2003) · Journal of Inorganic Biochemistry · doi:10.1016/s0162-0134(03)00152-1 · Cited by 80
Lam, C.-W., Arlt, W., Chan, C.-K., Honour, J. W., Lin, C. J., Tong, S.-F., Choy, K.-W., & Miller, W. L. (2001) · Molecular Genetics and Metabolism · doi:10.1006/mgme.2000.3134 · Cited by 65
Self-citationPallan, P. S., Nagy, L. D., Li, L., Gonzalez, E. R., Kramlinger, V. M., Azumaya, C. M., Wawrzak, Z., Waterman, M. R., Guengerich, F. P., & Egli, M. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.627265 · Cited by 65
“Human P450 17A1 Arg-358 has been implicated in b5 binding through NMR, chemical cross-linking, and other techniques (59, 72, 73).”
MethodThe molecular basis of premature adrenarche: an hypothesis
Miller, W. L. (1999) · Acta Paediatrica · doi:10.1111/j.1651-2227.1999.tb14405.x · Cited by 60
Self-citationHighly-selective 4-(1,2,3-triazole)-based P450c17a 17,20-lyase inhibitors
Rafferty, S. W., Eisner, J. R., Moore, W. R., Schotzinger, R. J., & Hoekstra, W. J. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.04.024 · Cited by 60
Pitfalls in characterizing P450c17 mutations associated with isolated 17,20 lyase deficiency
Gupta, M. K., Geller, D. H., & Auchus, R. J. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.9.7812 · Cited by 59
“COS-1 cells (18), yeast microsomes (19), and Escherichia coli”
Self-citationBiason-Lauber, A., Kempken, B., Werder, E., Forest, M. G., Einaudi, S., Ranke, M. B., Matsuo, N., Brunelli, V., Schönle, E. J., & Zachmann, M. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.3.6475 · Cited by 55
P450 oxidoreductase deficiency: a new form of congenital adrenal hyperplasia
Flück, C. E., & Miller, W. L. (2006) · Current Opinion in Pediatrics · doi:10.1097/01.mop.0000236395.71956.5c · Cited by 57
Self-citationSteroid hormone synthesis in pregnancy
Kallen, C. B. (2004) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2004.08.009 · Cited by 67
“[143] Geller DH, Auchus RJ, Miller WL.”
BackgroundTee, M. K., Dong, Q., & Miller, W. L. (2008) · Endocrinology · doi:10.1210/en.2007-1527 · Cited by 55
“POR and P450c17 to promote 17,20 lyase activity (25, 26); and”
BackgroundSelf-citationGenetic variation in human P450 oxidoreductase
Miller, W. L., Huang, N., Agrawal, V., & Giacomini, K. M. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.09.017 · Cited by 54
Self-citationThe Role of Protein-Protein and Protein-Membrane Interactions on P450 Function
Scott, E. E., Wolf, C. R., Otyepka, M., Humphreys, S. C., Reed, J. R., Henderson, C. J., McLaughlin, L. A., Paloncýová, M., Navrátilová, V., Berka, K., et al. (2016) · Drug Metabolism and Disposition · doi:10.1124/dmd.115.068569 · Cited by 55
“R358Q, and R449L mutants of CYP17A1 reported to selectively depress the lyase activity (Geller et al., 1999) similarly prevented NMR changes indicative of b5-CYP17A1 physical complex formation.”
BackgroundResultInfluential46,XY Disorders of Sexual Development
Domenice, S., Arnhold, I. J. P., Costa, E. M. F., & Mendonca, B. B. (2013) · Europe PMC (PubMed Central) · Cited by 52
Bhatt, M. R., Khatri, Y., Rodgers, R. J., & Martin, L. L. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.02.033 · Cited by 63
Disorders of Androgen Synthesis – from Cholesterol to Dehydroepiandrosterone
Miller, W. L. (2005) · Medical Principles and Practice · doi:10.1159/000086185 · Cited by 61
“DNA sequencing showed that each was homozygous for a different mutation; in one patient, the arginine at position 347 was replaced with histidine (R347H) and, in the other patient, the arginine at position 358 was replaced with glutamine (R358Q). Transfection of COS-1 cells with vectors expressing these P450c17 mutant…”
BackgroundSelf-citationThe post-translational regulation of 17,20 lyase activity
Miller, W. L., & Tee, M. K. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.09.010 · Cited by 56
“…that these mutant forms of P450c17 had the same Michaelis constant (Km) as the wild-type enzyme, but had reduced maximum velocities (Vmax) for the 17,20 lyase reaction and were subject to competitive inhibition, confirming that the mutations did not affect the active site (Geller et al., 1999).”
BackgroundSelf-citationPeng, H.-M., Im, S.-C., Pearl, N. M., Turcu, A. F., Rege, J., Waskell, L., & Auchus, R. J. (2016) · Biochemistry · doi:10.1021/acs.biochem.6b00532 · Cited by 50
Self-citationThe Adrenal Cortex and its Disorders
Miller, W. L. (2009) · Brook's Clinical Pediatric Endocrinology · doi:10.1002/9781444316728.ch13 · Cited by 50
Self-citationDhir, V., Reisch, N., Bleicken, C., Lebl, J., Kamrath, C., Schwarz, H., Grötzinger, J., Sippell, W. G., Riepe, F. G., Arlt, W., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0172 · Cited by 52
Kurnaz, E., Baykan, E. K., Türkyılmaz, A., Yaralı, O., Abalı, Z. Y., Turan, S., Bereket, A., Çayır, A., & Güran, T. (2020) · Hormone Research in Paediatrics · doi:10.1159/000515079 · Cited by 48
Swart, A. C., Storbeck, K., & Swart, P. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2009.12.014 · Cited by 45
Cytochrome P450 17A1 Interactions with the FMN Domain of Its Reductase as Characterized by NMR
Estrada, D. F., Laurence, J. S., & Scott, E. E. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.677294 · Cited by 47
“Finally, reports that disrupted lyase activity resulting from mutations in the surface of CYP17A1 implicated in b5 binding (R347H and R358Q) can be partially overcome by the presence of both b5 and CPR together (58) and also suggest a b5-related enhancement of the CYP17A1 CPR complex.”
BackgroundFernández‐Cancio, M., Camats, N., Flück, C. E., Zalewski, A., Dick, B., Frey, B. M., Monné, R., Torán, N., Audí, L., & Pandey, A. V. (2018) · Pharmaceuticals · doi:10.3390/ph11020037 · Cited by 49
“Mutations identified on the surface of CYP17A1 (R347C/H, R358Q) have been proposed to diminish the interaction with POR but could not explain the mechanism of their specific effect on 17,20 lyase activity [27,35].”
BackgroundStewart, P. M., & Krone, N. P. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00015-8 · Cited by 61
Huang, N., Dardis, A., & Miller, W. L. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0411 · Cited by 42
Self-citationDiagnosis and Treatment of Disorders of Sexual Development
Rey, R. A., & Josso, N. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00119-0 · Cited by 40
Catalytically Relevant Electrostatic Interactions of Cytochrome P450c17 (CYP17A1) and Cytochrome b5
Peng, H., Liu, J., Forsberg, S. E., Tran, H. T., Anderson, S. M., & Auchus, R. J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.608919 · Cited by 42
“Studies of CYP17A1 mutations from patients with isolated 17,20-lyase deficiency (10, 12) demonstrate that alterations in the interaction of CYP17A1 with its redox partner proteins POR and b5 form the biochemical basis for this selective enzyme defect.”
BackgroundSelf-citationCytochrome b5: Novel roles in steroidogenesis
Storbeck, K., Swart, A. C., Goosen, P., & Swart, P. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.11.020 · Cited by 46
“significantly alter the active pocket of the enzyme as the Km for 17OH-PREG, the substrate for the 17,20-lyase reaction, remains unchanged (Auchus et al., 1998; Geller et al., 1999).”
InfluentialPandey, A. V., Flück, C. E., Huang, N., Tajima, T., Fujieda, K., & Miller, W. L. (2004) · Endocrine Research · doi:10.1081/erc-200044134 · Cited by 39
Self-citationA 3D model of human P450c21: study of the putative effects of steroid 21-hydroxylase gene mutations
Mornet, E., & Gibrat, J.-F. (2000) · Human Genetics · doi:10.1007/s004390051046 · Cited by 41
“Lee-Robichaud et al. (1998) and Geller et al. (1999) have shown that arginines R347 and R358 in P450c17 (the product of the CYP17 gene) are involved in the interaction with the redox partner but R356 in P450c21 does not correspond to one of these two residues.”
BackgroundP450 oxidoreductase deficiency
Miller, W. L., Huang, N., Flück, C. E., & Pandey, A. V. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17344-3 · Cited by 37
Self-citationCragun, D. L., Trumpy, S. K., Shackleton, C. H. L., Kelley, R. I., Leslie, N. D., Mulrooney, N. P., & Hopkin, R. J. (2004) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.30170 · Cited by 39
“There are two reasons why CYb5 is perhaps a less likely candidate: (1) When expressed in yeast with human CYP17 and CPR, CYb5 does not appear to significantly alter 17-a-hydroxylase activity [Geller et al., 1999] and (2) the only patient reported with a mutation Fig.”
BackgroundQiao, J. (2003) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(02)00156-9 · Cited by 36
Assessment of the ability of type 2 cytochrome b5 to modulate 17,20-lyase activity of human P450c17
Soucy, P., & Luu-The, V. (2002) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(01)00171-6 · Cited by 38
Cytochrome b5 modulates multiple reactions in steroidogenesis by diverse mechanisms
Storbeck, K., Swart, A. C., Fox, C.-L., & Swart, P. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.11.024 · Cited by 36
ten Kate‐Booij, M. J. (2004) · Human Reproduction · doi:10.1093/humrep/deh065 · Cited by 34
“Others (Van den Akker et al., 2002) explained the more deleterious effect of the R347C mutation as compared to the R347H mutation described previously (Geller et al., 1999) on the basis of a possibility to form disulphide bridges in the R347C protein.”
BackgroundAchermann, J. C., & Hughes, I. A. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00023-7 · Cited by 40
Katsumata, N., Satoh, M., Mikami, A., Mikami, S., Nagashima‐Miyokawa, A., Sato, N. S., Yokoya, S., & Tanaka, T. (2001) · Hormone Research in Paediatrics · doi:10.1159/000049986 · Cited by 34
Azziz, R. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.6.2513 · Cited by 35
“For example, 17,20-lyase activity can be modified by variations in the amounts of the cofactors P450-oxidoreductase (19, 20) and cytochrome b5 (21‐23), by changes in the structural elements that allow P450c17 to interact with P450oxidoreductase ( 24 ), and by the degree of P450c17 phosphorylation (25).”
BackgroundCYP17A1 mutations identified in 17 Chinese patients with 17α-hydroxylase/17,20-lyase deficiency
Yao, F., Huang, S., Kang, X., Zhang, W., Wang, P., & Tian, Q. (2012) · Gynecological Endocrinology · doi:10.3109/09513590.2012.705373 · Cited by 33
“In addition, 17,20-lyase activity is dependent on interaction with the P450 oxidoreductase binding site and the presence of cytochrome b5 [1].”
BackgroundJanner, M., Pandey, A. V., Mullis, P. E., & Flück, C. E. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02172 · Cited by 33
Lee-Robichaud, P., Akhtar, M., & Akhtar, M. (1999) · Biochemical Journal · doi:10.1042/0264-6021:3420309 · Cited by 32
Inherent steroid 17α,20-lyase activity in defunct cytochrome P450 17A enzymes
Gonzalez, E. R., Johnson, K. M., Pallan, P. S., Phan, T. T. N., Zhang, W., Li, L., Wawrzak, Z., Yoshimoto, F. K., Egli, M., & Guengerich, F. P. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.000504 · Cited by 32
“This phenomenon has been suggested to be due to a selective loss of b5 binding, in that some lyase activity could be restored by the addition of high concentrations of purified b5 to human P450 17A1 expressed in a heterologous yeast system (19).”
BackgroundComplex assembly on the human CYP17 promoter
Sewer, M. B., & Jagarlapudi, S. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.10.006 · Cited by 31
Storbeck, K., Kolar, N. W., Stander, M. A., Swart, A. C., Prevoo, D., & Swart, P. (2007) · Analytical Biochemistry · doi:10.1016/j.ab.2007.09.036 · Cited by 34
Kim, D., Kim, V., McCarty, K. D., & Guengerich, F. P. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100571 · Cited by 31
“Comparisons with P450 17A1 variants known to be deficient in lyase activity (3, 31, 43) and documented here (Table 1) showed the importance of the P450 17A1 residues Arg-347 and Arg-358, previously proposed to be involved in the interaction (3, 5, 31–36).”
BackgroundHlavica, P. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-16009-2_10 · Cited by 32
Wang, Y.-H., Tee, M. K., & Miller, W. L. (2010) · Endocrinology · doi:10.1210/en.2009-1247 · Cited by 31
“These include the molar ratio of P450 oxidoreductase to P450c17 (44, 45), the allosteric action of cytochrome b5 (13, 23), and the Ser/Thr phosphorylation of P450c17 (7–9) (for review see Ref.”
BackgroundSelf-citationBortolato, M., Frau, R., Godar, S. C., Mosher, L. J., Paba, S., Marrosu, F., & Devoto, P. (2013) · Journal of Neuroendocrinology · doi:10.1111/jne.12066 · Cited by 34
Apparent pregnene hydroxylation deficiency (APHD): seeking the parentage of an orphan metabolome
Shackleton, C. H. L., & Malunowicz, E. (2003) · Steroids · doi:10.1016/s0039-128x(03)00115-6 · Cited by 31
Miller, W. L., & Portale, A. A. (1999) · Current Opinion in Pediatrics · doi:10.1097/00008480-199908000-00012 · Cited by 31
Self-citationMiller, W. L. (2012) · Science Signaling · doi:10.1126/scisignal.2003318 · Cited by 34
Self-citation
Metadata
- Authors
- Geller, D. H., Auchus, R. J., & Miller, W. L.
- Affiliations
- University of California, San Francisco (US)
- Corresponding author
- Miller, Walter L.
- Venue
- Molecular Endocrinology
- Publisher
- The Endocrine Society
- Published
- 1999-01
- Volume
- 13
- Issue
- 1
- Pages
- 167-175
- ISSN
- 0888-8809 (ISSN-L)
- 1944-9917
- OpenAlex
- W2010143253
- Semantic Scholar
- 1629c1603f8c3c9504769108dce25a20b5c7258c
- Cited by
- 183
- References
- 34
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 6 · 2023: 3 · 2022: 3 · 2021: 6 · 2020: 1 · 2019: 1 · 2018: 3 · 2017: 6 · 2016: 9 · 2015: 5 · 2014: 8 · 2013: 6 · 2012: 4
- FWCI
- 3.43
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Molecular Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Pediatric Endocrine Society
- National Institutes of Health (5r01dk042154-09)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-37922, DK 42154, R01DK037922)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (U54HD034449)
- Topics
- Physical Sciences › Chemistry › Organic Chemistry › Steroid Chemistry and Biochemistry
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- P450c17, 17,20-lyase activity, cytochrome P450 oxidoreductase, cytochrome b5, electron transfer, allosteric regulation, competitive inhibition, Michaelis constant, steroidogenesis, glucocorticoids
- MeSH terms
- Animals, Cytochrome P-450 Enzyme System, Humans, 17-alpha-Hydroxypregnenolone, Kinetics, Microsomes, Mutation, Oxidoreductases, Recombinant Proteins, Steroid 17-alpha-Hydroxylase, Structure-Activity Relationship, Yeasts, Cytochromes b5, COS Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.